Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Genetic contribution in low back pain: a prospective genetic association study.

Margarit C, Roca R, Inda MD, Muriel J, Ballester P, Moreu R, Conte AL, Nuñez A, Morales D, Peiró A.

Pain Pract. 2019 Jul 3. doi: 10.1111/papr.12816. [Epub ahead of print]

PMID:
31269327
2.

Randomized, Controlled, Crossover Study of Self-administered Jacobson Relaxation in Chronic, Nonspecific, Low-back Pain.

Mateu M, Alda O, Inda MD, Margarit C, Ajo R, Morales D, van-der Hofstadt CJ, Peiró AM.

Altern Ther Health Med. 2018 Nov;24(6):22-30.

PMID:
30982021
3.

OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids.

Margarit C, Ballester P, Inda MD, Roca R, Gomez L, Planelles B, Ajo R, Morales D, Peiro AM.

Pain Physician. 2019 Jan;22(1):97-107.

4.

Sleep problems in adults with autism spectrum disorder and intellectual disability.

Ballester P, Martínez MJ, Javaloyes A, Inda MD, Fernández N, Gázquez P, Aguilar V, Pérez A, Hernández L, Richdale AL, Peiró AM.

Autism Res. 2019 Jan;12(1):66-79. doi: 10.1002/aur.2000. Epub 2018 Oct 1.

PMID:
30273974
5.

Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids.

Planelles B, Margarit C, Ajo R, Sastre Y, Muriel J, Inda MD, Esteban MD, Peiró AM.

Acta Anaesthesiol Scand. 2019 Feb;63(2):248-258. doi: 10.1111/aas.13243. Epub 2018 Aug 14.

PMID:
30109708
6.

OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients.

Muriel J, Margarit C, Planelles B, Serralta MJ, Puga C, Inda MD, Cutillas E, Morales D, Horga JF, Peiró AM.

Ann N Y Acad Sci. 2018 May 20. doi: 10.1111/nyas.13735. [Epub ahead of print]

PMID:
29781244
7.

β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis.

Roca R, Esteban P, Zapater P, Inda MD, Conte AL, Gómez-Escolar L, Martínez H, Horga JF, Palazon JM, Peiró AM.

Mol Med Rep. 2018 Jun;17(6):7987-7995. doi: 10.3892/mmr.2018.8820. Epub 2018 Mar 29.

PMID:
29620176
8.

Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer.

Mafé JJ, Planelles B, Asensio S, Cerezal J, Inda MD, Lacueva J, Esteban MD, Hernández L, Martín C, Baschwitz B, Peiró AM.

J Thorac Dis. 2017 Aug;9(8):2534-2543. doi: 10.21037/jtd.2017.07.51.

9.

Erectile dysfunction in patients with chronic pain treated with opioids.

Ajo R, Segura A, Inda MD, Margarit C, Ballester P, Martínez E, Ferrández G, Sánchez-Barbie Á, Peiró AM.

Med Clin (Barc). 2017 Jul 21;149(2):49-54. doi: 10.1016/j.medcli.2016.12.038. Epub 2017 Feb 22. English, Spanish.

PMID:
28236471
10.

The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).

Ajo R, Segura A, Mira L, Inda MD, Alfayate R, Sánchez-Barbie A, Margarit C, Peiró AM.

Aging Male. 2017 Mar;20(1):1-8. doi: 10.1080/13685538.2016.1185408. Epub 2016 Oct 18.

PMID:
27750480
11.

Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma.

Rodón L, Gonzàlez-Juncà A, Inda Mdel M, Sala-Hojman A, Martínez-Sáez E, Seoane J.

Cancer Discov. 2014 Oct;4(10):1230-41. doi: 10.1158/2159-8290.CD-14-0275. Epub 2014 Aug 1.

12.

Glioblastoma multiforme: a look inside its heterogeneous nature.

Inda MM, Bonavia R, Seoane J.

Cancers (Basel). 2014 Jan 27;6(1):226-39. doi: 10.3390/cancers6010226.

13.

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.

Fenton TR, Nathanson D, Ponte de Albuquerque C, Kuga D, Iwanami A, Dang J, Yang H, Tanaka K, Oba-Shinjo SM, Uno M, Inda MM, Wykosky J, Bachoo RM, James CD, DePinho RA, Vandenberg SR, Zhou H, Marie SK, Mischel PS, Cavenee WK, Furnari FB.

Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14164-9. doi: 10.1073/pnas.1211962109. Epub 2012 Aug 13.

14.

Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas.

Muñoz J, Inda MM, Lázcoz P, Zazpe I, Fan X, Alfaro J, Tuñón T, Rey JA, Castresana JS.

ISRN Neurol. 2012;2012:576578. doi: 10.5402/2012/576578. Epub 2012 Jan 9.

15.

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.

Li M, Mukasa A, Inda MM, Zhang J, Chin L, Cavenee W, Furnari F.

J Exp Med. 2011 Dec 19;208(13):2657-73. doi: 10.1084/jem.20111102. Epub 2011 Dec 12.

16.

Heterogeneity maintenance in glioblastoma: a social network.

Bonavia R, Inda MM, Cavenee WK, Furnari FB.

Cancer Res. 2011 Jun 15;71(12):4055-60. doi: 10.1158/0008-5472.CAN-11-0153. Epub 2011 May 31. Review.

17.

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.

Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, Brennan C, Johns TG, Bachoo R, Hadwiger P, Tan P, Depinho RA, Cavenee W, Furnari F.

Genes Dev. 2010 Aug 15;24(16):1731-45. doi: 10.1101/gad.1890510.

18.

Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.

Nitta M, Kozono D, Kennedy R, Stommel J, Ng K, Zinn PO, Kushwaha D, Kesari S, Inda MM, Wykosky J, Furnari F, Hoadley KA, Chin L, DePinho RA, Cavenee WK, D'Andrea A, Chen CC.

PLoS One. 2010 May 24;5(5):e10767. doi: 10.1371/journal.pone.0010767. Erratum in: PLoS One. 2011;6(4). doi:10.1371/annotation/9b9cc4ae-ad56-464f-ab97-59f096b5c0eb. Inda, Maria-del-Mar [added]; Wykosky, Jill [added].

19.
20.

Chromosomal abnormalities in human glioblastomas: gain in chromosome 7p correlating with loss in chromosome 10q.

Inda MM, Fan X, Muñoz J, Perot C, Fauvet D, Danglot G, Palacio A, Madero P, Zazpe I, Portillo E, Tuñón T, Martínez-Peñuela JM, Alfaro J, Eiras J, Bernheim A, Castresana JS.

Mol Carcinog. 2003 Jan;36(1):6-14.

PMID:
12503074

Supplemental Content

Loading ...
Support Center